C+ AKT: Wiad, AON,

    

© THE ROCKEFELLER UNIVERSITY

m
Z 1230 YORK AVENUE NEW YORK, NY 10021

of Rockefeller

e\ Un iversity
ae January 26, 1979

JOSHUA LEDERBERG

PRESIDENT

Dr. William J. Gartland

Director

Office of Recombinant DNA Activities
National Institutes of Health
Building 31, Room 4A52

Bethesda, Maryland 20014

Dear Dr. Gartland:

To answer your memorandum dated 15 December 1978,
I am pleased to inform you that the Institutional Bio-
safety Committee of The Rockefeller University was re-
organized on 9 January 1979 and now meets the require-
ments of the Revised Guidelines.

Dr. Margeris A. Jesaitis has been reappointed the
Chairman of this Committee, and as such will serve as
the Institutional Official responsible for certifying
that all facilities and procedures involved in the
recombinant DNA research are reviewed and judged to be
in compliance with the NIH guidelines. Mr. Paul R.
Penndorf, Director of Safety and Code Compliance, has-
been named the Biological Safety Officer of the Univer-
sity; he has had wide experience here with procedures
and facilities for biomedical research. Professor
Attallah Kappas, M.D., Physician-in-Chief of The
Rockefeller University Hospital, and his clinical asso-
ciates are available as needed to advise the IBC in the
matter of health surveillance of the personnel working
in P3 facilities.

Dr. Peter J. Gomatos of the Sloan-Kettering Insti-
tute and Dr. Richard B. Roberts of the New York Hospital-
Cornell Medical Center agreed to serve as non-affiliated
members of the IBC. The Roster of the Committee and
Curricula Vitae of each member are enclosed.

Sincerely,

Joshua Lederberg

cc: Dr. Margeris A. Jesaitis

bec: Mr. Paul Penndorf
Mr. David Lyons
Mr. Rodney Nichols
Dr. Attallah Kappas